找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cancer Prevention II; Hans-J?rg Senn,Ursula Kapp,Florian Otto Conference proceedings 2009 Springer-Verlag Berlin Heidelberg 2009 ER-negati

[復(fù)制鏈接]
樓主: Malnutrition
21#
發(fā)表于 2025-3-25 06:46:05 | 只看該作者
22#
發(fā)表于 2025-3-25 07:55:34 | 只看該作者
Calculi of Names: Free and Modalnoids (analogs of retinoids that bind and activate RXR receptors), tyrosine kinase inhibitors (such as EGFR inhibitors and dual kinase inhibitors that block EGFR and HER2/neu signaling), and cyclo-oxygenase 2 (COX-2) inhibitors all prevent ER-negative breast cancer in transgenic mice that develop ER
23#
發(fā)表于 2025-3-25 11:53:19 | 只看該作者
24#
發(fā)表于 2025-3-25 19:17:50 | 只看該作者
25#
發(fā)表于 2025-3-25 21:45:16 | 只看該作者
26#
發(fā)表于 2025-3-26 04:00:45 | 只看該作者
27#
發(fā)表于 2025-3-26 08:14:15 | 只看該作者
0080-0015 Switzerland for a 3-day conference to discuss important current issues of clinical cancer prevention. The meeting was again organized and co-sponsored by St. Gallen Oncology Conferences (SONK). While SONK has been extremely successful in organizing large international c- gresses on “Primary Therapy
28#
發(fā)表于 2025-3-26 08:38:33 | 只看該作者
New Era for Robust Speech Recognitione trial. This warrants further research on fenretinide mechanisms of action and potential efficacy and provides the rationale for a phase III primary prevention trial in young women at high risk for breast cancer.
29#
發(fā)表于 2025-3-26 13:43:04 | 只看該作者
Existence and Reference in Medieval Logicst, multicentre, randomised controlled clinical trial looking at the long-term chemopre-vention effect of esomeprazole with or without aspirin. More than 85% of the participants tolerated the medications at the initial intended doses, and the drop-out rate has been 7%; the interim analysis is due in 2011.
30#
發(fā)表于 2025-3-26 17:29:28 | 只看該作者
Free Logic and Definite Descriptionsrophage-mediated immune surveillance. This observation and data demonstrating that non-steroidal anti-inflammatory drugs (NSAIDs) protect against prostate cancer provide the justification for trials of these two agents combined with short course intermittent anti-androgen therapy in populations at high risk of prostate cancer.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-21 23:34
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
施甸县| 板桥市| 石河子市| 蓬莱市| 分宜县| 潮州市| 翁源县| 大方县| 开江县| 玛纳斯县| 甘洛县| 江陵县| 永嘉县| 庐江县| 海城市| 长葛市| 漳浦县| 神池县| 崇文区| 会泽县| 长岭县| 赞皇县| 柘城县| 清徐县| 乌苏市| 北海市| 车险| 郴州市| 深水埗区| 盈江县| 宝清县| 台南县| 灵宝市| 琼海市| 高台县| 孝昌县| 湘西| 钦州市| 仲巴县| 宣武区| 莫力|